微信关注
Total item
Cart Subtotal
￥ 0.00 Protein Tyrosine Kinases
-
PF-06463922
Catalog No. A14207 ALK 抑制剂PF-06463922是一种有效的双重ALK/ROS1抑制剂，对ROS1，ALK（WT）和ALK（L1196M）的Ki分别为<0.02 nM，<0.07 nM和0.7 nM。 了解更多 -
LDK378 (Ceritinib) dihydrochloride
Catalog No. A15142 ALK 抑制剂LDK378 (Ceritinib) dihydrochloride是有效的抗ALK抑制剂，IC50为0.2 nM，对IGF-1R和InsR的选择性分别为40倍和35倍。 了解更多 -
Entrectinib
Catalog No. A15801 TRK, ROS1, ALK 抑制剂Entrectinib，也称为RXDX-101和NMS-E628，是TrkA，TrkB和TrkC以及ROS1和ALK的小分子抑制剂，具有很高的效力和选择性。 了解更多 -
Crizotinib hydrochloride
Catalog No. A16245 c-Met/NPM-ALK 抑制剂Crizotinib hydrochloride是c-Met激酶和NPM-ALK的抑制剂。 了解更多 -
PHA-665752
Catalog No. A10713 -
JNJ-38877605
Catalog No. A10493 -
BMS-777607
Catalog No. A10153 c-Met 抑制剂BMS-777607是一种MET酪氨酸激酶抑制剂，与c-Met蛋白或HGFR结合，可防止HGF结合并破坏MET信号通路。 了解更多 -
PF-04217903
Catalog No. A10711 c-Met 抑制剂PF-04217903是一种选择性的，ATP竞争性c-Met抑制剂，在A549细胞中IC50为4.8 nM，对致癌基因突变型敏感(对Y1230C突变型没有活性)。 了解更多 -
AMG 208
Catalog No. A10063 -
AMG-458
Catalog No. A11055 -
EMD-1214063
Catalog No. A11257 c-Met 抑制剂EMD-1214063是MET酪氨酸激酶的抑制剂，IC50为4 nM，作用于c-Met比作用于IRAK4， TrkA， Axl， IRAK1和Mer选择性高200倍以上。具有潜在的抗肿瘤活性。它与MET酪氨酸激酶结合并破坏MET信号转导途径，这可能在过表达该激酶的肿瘤细胞中诱导凋亡。 了解更多 -
Volitinib (Savolitinib, AZD-6094)
Catalog No. A14419 -
c-Met inhibitor 1
Catalog No. A15049 -
Glumetinib (SCC-244)
Catalog No. A18328 c-Met inhibitorGlumetinib (SCC244) is a potent and highly selective c-Met kinase inhibitor with an IC50 of 0.42 nM. Glumetinib shows antitumor activity and a superior safety margin. 了解更多 -
JNJ-38877618
Catalog No. A18325 c-Met inhibitorJNJ-38877618 is a novel potent, highly selective, orally bioavailable c-Met tyrosine kinase inhibitor with Kd of 1.2, 2.1 and 21 nM for WT, M1250T and Y1235D mutants MET, respectively. 了解更多 -
BMS 777607
Catalog No. A21638 c-Met/Axl/Ron/Tyro3 inhibitorBMS 777607 is a Met-related inhibitor for c-Met, Axl, Ron and Tyro3 with IC50s of 3.9 nM, 1.1 nM, 1.8 nM and 4.3 nM, respectively. 了解更多 -
LY2801653 dihydrochloride
Catalog No. A15150 -
PF-04217903 methanesulfonate
Catalog No. A15208 c-Met 抑制剂PF-04217903 methanesulfonate是一种选择性ATP竞争性c-Met抑制剂，IC50为4.8 nM，易致癌突变（对Y1230C突变体无活性）。 了解更多 -
LY2801653 (Merestinib)
Catalog No. A12557 -
c-Met inhibitor 2
Catalog No. A16256 -
Glesatinib hydrochloride
Catalog No. A16257 -
ARQ 197 (Tivantinib)
Catalog No. A11087 c-Met 抑制剂ARQ-197是c-Met受体酪氨酸激酶的选择性抑制剂, 在无细胞试验中Ki为0.355 μM，对Ron几乎没有作用活性，对EGFR， InsR， PDGFRα和FGFR1/4没有抑制作用。 了解更多 -
PF-2341066 (Crizotinib)
Catalog No. A10712 ALK/ c-Met 抑制剂PF-2341066 (Crizotinib)是c-Met激酶和NPM-ALK的抑制剂。PF-2341066抑制ALK阳性ALCL细胞中的细胞增殖（IC50 = 30 nM）。 了解更多 -
R406 besylate
Catalog No. A10769 Syk 抑制剂R406 besylate是一种口服酪氨酸激酶抑制剂，IC50为41 nM。对Syk抑制作用强，但是不抑制Lyn，对Flt3的作用比对Syk低5倍。 了解更多 -
R406 (Tamatinib)
Catalog No. A10770 Syk 抑制剂R406 (Tamatinib)是一种口服酪氨酸激酶抑制剂，IC50为41 nM。对Syk抑制作用强，但是不抑制Lyn，对Flt3的作用比对Syk低5倍。 了解更多 -
Tandutinib (MLN518)
Catalog No. A10887 -
TG-101348 (Fedratinib, SAR302503)
Catalog No. A11082 JAK2/FLT3 抑制剂TG-101348 (Fedratinib,SAR302503)是Janus相关激酶2的口服生物利用型，ATP竞争性和选择性抑制剂，在无细胞试验中IC50为3 nM，作用于JAK2比作用于JAK1和JAK3选择性高35和334倍,具有潜在的抗肿瘤活性。 了解更多 -
TCS 359
Catalog No. A12427 -
AST 487
Catalog No. A15003 -
SB1317 (TG02)
Catalog No. A13454 CDK/JAK2/FLT3 抑制剂SB1317是细胞周期蛋白依赖性激酶（CDKs）、类FMS酪氨酸激酶-3（FLT3）和Janus激酶2（JAK2）的有效抑制剂，CDK2、JAK2和FLT3的IC50值分别为13nM、56nM和73nM。 了解更多 -
PROTAC FLT-3 degrader 1
Catalog No. A18682 FLT-3 ITD degraderPROTAC FLT-3 degrader 1 is an FLT-3 internal tandem duplication (ITD) degrader with an IC50 0.6 nM. Anti-proliferative activity; apoptosis induction. 了解更多 -
Gilteritinib hemifumarate
Catalog No. A18235 FLT3/AXL inhibitorGilteritinib hemifumarate is a potent FLT3/AXL inhibitor with IC50 of 0.29 nM/0.73 nM, respectively. 了解更多
FILTER BY:
购物选项
- 分类
-
- EGFR/HER2 (103)
- FGFR (40)
- PDGFR (42)
- VEGFR (93)
- IGF-1R (14)
- FLT3 (37)
- c-MET (36)
- ALK (20)
- Src (39)
- c-Kit (40)
- Tie-2 (7)
- Tyrosine kinase (3)
- Trk Receptors (14)
- CSF-1R (15)
- TAM Receptor (16)
- Ephrin Receptor (1)
- ITK (8)
- IRAK (6)
- DDR (3)
- 作用机制
-
- Inhibitor (抑制剂) (383)
- Agonist (激动剂) (2)
- Antagonist (拮抗剂) (2)
- Activator (激活剂) (2)
- Degrader (降解剂) (1)
- Stimulator (刺激物) (1)
- 靶点
-
- Abl (6)
- ALK (1)
- Aurora A (6)
- Aurora B (2)
- Aurora C (1)
- Axl (1)
- B-Raf (4)
- Bcr-Abl (1)
- C-Raf (Raf-1) (4)
- CDK (2)
- CDK2 (2)
- CDK4 (1)
- Chk2 (1)
- CSF1R (9)
- DNMT (1)
- EGFR (22)
- EGFR Exon 19 Deletion (1)
- EGFR L858R (5)
- EGFR L861Q (2)
- EGFR T790M (9)
- EGFR wild type (2)
- EphB4 (2)
- ErbB2 (3)
- ErbB3 (1)
- ErbB4 (2)
- FAK (1)
- FGFR (2)
- FGFR1 (23)
- FGFR2 (11)
- FGFR3 (12)
- FGFR4 (9)
- FLT3 (27)
- HER2 (1)
- IGF1R (1)
- JAK2 (8)
- JAK3 (1)
- Kit (14)
- Lck (2)
- Lyn (1)
- Mer (1)
- PDGFR (1)
- PDGFRα (10)
- PDGFRβ (19)
- PKCα (1)
- PKCβ (1)
- RET (7)
- Src (5)
- STAT1 (1)
- Syk (1)
- TrkA (1)
- VEGFR1 (FLT1) (12)
- VEGFR2 (FLK1) (25)
- VEGFR3 (FLT4) (11)
ADOOQ 产品质量保证
We promise all products to perform as described.